Trinity Biotech (TRIB) Capital Expenditures Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Capital Expenditures Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | -47.73% |
| 10 | Trinity Biotech | 105.39 Mn | 100.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 37.20% |
| Dec 31, 2023 | 47.37% |
| Sep 30, 2023 | 60.12% |
| Dec 31, 2022 | 16.67% |
| Jun 30, 2022 | 63.24% |
| Dec 31, 2016 | -0.60% |
| Dec 31, 2015 | -22.84% |
| Dec 31, 2014 | 22.99% |
| Dec 31, 2013 | 21.78% |
| Dec 31, 2012 | -7.80% |
| Dec 31, 2011 | -17.35% |
| Dec 31, 2010 | -13.84% |
| Sep 30, 2010 | 5.31% |
| Jun 30, 2010 | 41.09% |
| Mar 31, 2010 | 7.08% |